Press Releases

We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on...

DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors...

Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...

DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing...

DaVita Inc. , today announced results for the quarter ended March 31, 2001. Net earnings for the first quarter were $21.3 million or $0.24 per share. Continental U.S. EBITDA (earnings before...

DaVita Inc. , announced today that it has completed the sale of $225 million of its 9 1/4% Senior Subordinated Notes Due 2001 (the "Notes") in a private offering. The Notes mature on April 15,...

To: Members of the Investment Community From: LeAnne Zumwalt, Vice President Re: DaVita Inc. Q1 2001 Earnings Release Date: April 6, 2001 We are planning a conference call to discuss our Q1 2001...

DaVita Inc. , today announced results for the quarter and year ended December 31, 2000. Net earnings for the fourth quarter were $15.3 million or $0.18 per share. Continental U.S. EBITDA (earnings...

In SFW001B, DaVita, Inc. Invites You to Join Its Fourth Quarter Conference Call on the Web, moved earlier today, the "when" section of the advisory should read "11:00 EST February 27, 2001" rather...

DaVita Inc. announced today that representatives of the Civil Division of the United States Attorney's Office for the Eastern District of Pennsylvania have requested that the Company voluntarily...